US revokes visas of Indian executives over Fentanyl Precursor Trafficking

September 18, 2025

New Delhi: The US Embassy in New Delhi announced on Thursday that it has revoked the visas of several Indian business executives and their families for their alleged involvement in the trafficking of fentanyl precursors. The move comes as part of a broader US initiative to combat the growing threat of synthetic drugs, particularly fentanyl, which has been linked to a devastating increase in overdose deaths in the United States.

According to the embassy, ​​these actions are intended to send a clear message that individuals and organisations engaged in the illicit production and trafficking of controlled substances will face serious consequences, including denial of entry to the United States. The embassy stressed that those whose visas have been revoked include executives of companies known to be involved in the trafficking of fentanyl precursors. These individuals, along with their immediate family members, are now considered ineligible to travel to the United States.

The embassy said such individuals will also be flagged during future visa applications, further reinforcing the United States’ zero-tolerance policy towards drug trafficking activities linked to the US opioid crisis.

Chargé d’Affaires Jörgen Andrews underscored the seriousness of the situation, saying that anyone facilitating the flow of illicit drugs into the United States will be held accountable and denied entry into the country. He reiterated that stopping the import of fentanyl and its precursors is one of Washington’s highest priorities and the recent visa revocation is in line with that commitment.

The embassy also expressed its appreciation for the ongoing cooperation of the Indian government in addressing the global challenge of synthetic drug trafficking. The announcement followed a warning by former US President Donald Trump, who had identified 23 countries, including India, as major drug-producing or drug-trafficking countries.

In his remarks, Trump warned these countries that they must take decisive action to cut off the supply of drugs or face serious consequences. While he noted that not all countries on the list were necessarily failing in their cooperation, he stressed the urgent need for global accountability and action.

The list of countries identified by the US includes India, Pakistan, China, Afghanistan, Bahamas, Belize, Bolivia, Burma, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Laos, Mexico, Nicaragua, Panama, Peru and Venezuela. The US government’s decision to revoke visas reflects an aggressive stance against any involvement, directly or indirectly, in the illicit drug trade, and highlights the growing scope of its enforcement efforts beyond its borders.

The US embassy reiterated its position in a statement posted on the social media platform X, confirming that visa revocations have already been issued against company executives and their families found to be involved in illegal activities involving fentanyl and other controlled substances. The message was clear: Individuals who contribute to the drug crisis in the United States, regardless of their location or business ties, will not be allowed to enter or work within the country.